Your browser doesn't support javascript.
loading
Effectiveness and safety of metoclopramide in treatment of intractable hiccup: a protocol of systematic review and meta-analysis.
Wang, Die; Zi, Changyan; Zhang, Baocheng; Wang, Baojia; Chen, Tao; Wang, Long; Gao, Yongxiang.
Affiliation
  • Wang D; Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
  • Zi C; Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
  • Zhang B; Chengdu University of Traditional Chinese Medicine Affiliated Hospital, Chengdu, Sichuan, China.
  • Wang B; Chengdu University of Traditional Chinese Medicine Affiliated Hospital, Chengdu, Sichuan, China.
  • Chen T; Chengdu University of Traditional Chinese Medicine Affiliated Hospital, Chengdu, Sichuan, China.
  • Wang L; Chengdu University of Traditional Chinese Medicine Affiliated Hospital, Chengdu, Sichuan, China.
  • Gao Y; Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China drgaoyx@cdutcm.edu.cn.
BMJ Open ; 12(10): e059887, 2022 10 06.
Article in En | MEDLINE | ID: mdl-36202584
ABSTRACT

INTRODUCTION:

Hiccup is a common disease that not only occurred on adults but also on infants, which can severely do harm to patients' physical and psychological health. Metoclopramide has been reported to have effects on intractable hiccup. However, there is a limited evidence that describes the efficacy and safety of metoclopramide in the treatment of intractable hiccup. The aim of this article is to obtain evidence on the effectiveness and safety of metoclopramide in treating patients with intractable hiccup. METHODS AND

ANALYSIS:

We will search the following databases, including PubMed, Cochrane Library, Embase, Web of Science, CBM, Wan-fang, VIP database, CNKI and MEDLINE from their inception to 11 November 2021. All the randomised controlled trials associated with metoclopramide in treating intractable hiccup will be included. Articles screened, selected and extracted will be performed by two researchers independently. The risk of bias will be assessed by using the Cochrane Collaboration. We will carry out the meta-analysis by using RevMan V.5.4 software. PROSPERO REGISTRATION NUMBER CRD42021293000.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hiccup Type of study: Clinical_trials / Guideline / Systematic_reviews Limits: Adult / Humans Language: En Journal: BMJ Open Year: 2022 Document type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hiccup Type of study: Clinical_trials / Guideline / Systematic_reviews Limits: Adult / Humans Language: En Journal: BMJ Open Year: 2022 Document type: Article Affiliation country: China